Cargando…

Design of bacteriophage T4-based artificial viral vectors for human genome remodeling

Designing artificial viral vectors (AVVs) programmed with biomolecules that can enter human cells and carry out molecular repairs will have broad applications. Here, we describe an assembly-line approach to build AVVs by engineering the well-characterized structural components of bacteriophage T4. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jingen, Batra, Himanshu, Ananthaswamy, Neeti, Mahalingam, Marthandan, Tao, Pan, Wu, Xiaorong, Guo, Wenzheng, Fokine, Andrei, Rao, Venigalla B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229621/
https://www.ncbi.nlm.nih.gov/pubmed/37253769
http://dx.doi.org/10.1038/s41467-023-38364-1
_version_ 1785051303911620608
author Zhu, Jingen
Batra, Himanshu
Ananthaswamy, Neeti
Mahalingam, Marthandan
Tao, Pan
Wu, Xiaorong
Guo, Wenzheng
Fokine, Andrei
Rao, Venigalla B.
author_facet Zhu, Jingen
Batra, Himanshu
Ananthaswamy, Neeti
Mahalingam, Marthandan
Tao, Pan
Wu, Xiaorong
Guo, Wenzheng
Fokine, Andrei
Rao, Venigalla B.
author_sort Zhu, Jingen
collection PubMed
description Designing artificial viral vectors (AVVs) programmed with biomolecules that can enter human cells and carry out molecular repairs will have broad applications. Here, we describe an assembly-line approach to build AVVs by engineering the well-characterized structural components of bacteriophage T4. Starting with a 120 × 86 nm capsid shell that can accommodate 171-Kbp DNA and thousands of protein copies, various combinations of biomolecules, including DNAs, proteins, RNAs, and ribonucleoproteins, are externally and internally incorporated. The nanoparticles are then coated with cationic lipid to enable efficient entry into human cells. As proof of concept, we assemble a series of AVVs designed to deliver full-length dystrophin gene or perform various molecular operations to remodel human genome, including genome editing, gene recombination, gene replacement, gene expression, and gene silencing. These large capacity, customizable, multiplex, and all-in-one phage-based AVVs represent an additional category of nanomaterial that could potentially transform gene therapies and personalized medicine.
format Online
Article
Text
id pubmed-10229621
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102296212023-06-01 Design of bacteriophage T4-based artificial viral vectors for human genome remodeling Zhu, Jingen Batra, Himanshu Ananthaswamy, Neeti Mahalingam, Marthandan Tao, Pan Wu, Xiaorong Guo, Wenzheng Fokine, Andrei Rao, Venigalla B. Nat Commun Article Designing artificial viral vectors (AVVs) programmed with biomolecules that can enter human cells and carry out molecular repairs will have broad applications. Here, we describe an assembly-line approach to build AVVs by engineering the well-characterized structural components of bacteriophage T4. Starting with a 120 × 86 nm capsid shell that can accommodate 171-Kbp DNA and thousands of protein copies, various combinations of biomolecules, including DNAs, proteins, RNAs, and ribonucleoproteins, are externally and internally incorporated. The nanoparticles are then coated with cationic lipid to enable efficient entry into human cells. As proof of concept, we assemble a series of AVVs designed to deliver full-length dystrophin gene or perform various molecular operations to remodel human genome, including genome editing, gene recombination, gene replacement, gene expression, and gene silencing. These large capacity, customizable, multiplex, and all-in-one phage-based AVVs represent an additional category of nanomaterial that could potentially transform gene therapies and personalized medicine. Nature Publishing Group UK 2023-05-30 /pmc/articles/PMC10229621/ /pubmed/37253769 http://dx.doi.org/10.1038/s41467-023-38364-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zhu, Jingen
Batra, Himanshu
Ananthaswamy, Neeti
Mahalingam, Marthandan
Tao, Pan
Wu, Xiaorong
Guo, Wenzheng
Fokine, Andrei
Rao, Venigalla B.
Design of bacteriophage T4-based artificial viral vectors for human genome remodeling
title Design of bacteriophage T4-based artificial viral vectors for human genome remodeling
title_full Design of bacteriophage T4-based artificial viral vectors for human genome remodeling
title_fullStr Design of bacteriophage T4-based artificial viral vectors for human genome remodeling
title_full_unstemmed Design of bacteriophage T4-based artificial viral vectors for human genome remodeling
title_short Design of bacteriophage T4-based artificial viral vectors for human genome remodeling
title_sort design of bacteriophage t4-based artificial viral vectors for human genome remodeling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229621/
https://www.ncbi.nlm.nih.gov/pubmed/37253769
http://dx.doi.org/10.1038/s41467-023-38364-1
work_keys_str_mv AT zhujingen designofbacteriophaget4basedartificialviralvectorsforhumangenomeremodeling
AT batrahimanshu designofbacteriophaget4basedartificialviralvectorsforhumangenomeremodeling
AT ananthaswamyneeti designofbacteriophaget4basedartificialviralvectorsforhumangenomeremodeling
AT mahalingammarthandan designofbacteriophaget4basedartificialviralvectorsforhumangenomeremodeling
AT taopan designofbacteriophaget4basedartificialviralvectorsforhumangenomeremodeling
AT wuxiaorong designofbacteriophaget4basedartificialviralvectorsforhumangenomeremodeling
AT guowenzheng designofbacteriophaget4basedartificialviralvectorsforhumangenomeremodeling
AT fokineandrei designofbacteriophaget4basedartificialviralvectorsforhumangenomeremodeling
AT raovenigallab designofbacteriophaget4basedartificialviralvectorsforhumangenomeremodeling